In the US, healthcare costs and prices have been increasing. According to the Centers for Medicare & Medicaid Services, U.S.

President Trump wants European countries to start buying U.S. chicken and eggs. But the U.K. and E.U. think American poultry ...

Spanish poultry group Uvesa, majority owned by Ukraine's MHP, is expanding with a new site in the north of the country.

PARIS, March 31 (Reuters) - France's Ceva Animal Health has raised 5.5 billion euros ($5.95 billion) in equity, boosting its valuation to 9.2 billion euros, as shareholders including the ...

Thousands of federal workers were bracing for pink slips Friday as Health and Human Services Secretary Robert F. Kennedy Jr. begins dismantling the sprawling federal agency responsible for ...

After that, Merck has an animal health segment that earned ~$6bn last year, or 9% of revenues, diabetes segment that earned $2.3bn, or 4% of revenues, virology segment, $1.8bn, 2% of revenues ...

Merck has recently achieved a significant milestone with the European Commission's approval of its pneumococcal vaccine CAPVAXIVE®, boosting its portfolio in the vaccines market. Despite this ...

Merck (MRK), known as MSD outside of the United States and Canada, announced that the European Commission, or EC, has approved CAPVAXIVE, or Pneumococcal 21-valent Conjugate Vaccine, for active ...

Merck (MRK) has signed a licensing agreement for a heart disease drug developed by a Chinese company in a deal worth up to $2 billion, the latest in a series of cross-border deals between Western ...

Merck & Co. is handing over $200 million to China’s Hengrui Pharma for a phase 2-stage lipoprotein(a) (Lp(a)) inhibitor. In return for the ex-China rights to the drug, dubbed HRS-5346, Merck has ...

Alembic Pharmaceuticals and Amlan International, the animal health business of Oil-Dri Corporation of America, have entered into a strategic commercial agreement to introduce poultry health ...

(Reuters) -Merck has signed a licensing agreement for a heart disease drug with Jiangsu Hengrui Pharmaceuticals worth up to $2 billion, the latest in a series of deals U.S. drugmakers have ...